Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions Niken M. MahaweniGerard M. J. BosLotte Wieten Original Article Open access 02 March 2018 Pages: 861 - 872
Tumor-associated myeloid cells promote tumorigenesis of non-tumorigenic human and murine prostatic epithelial cell lines Stephanie N. SassKimberley D. RamseySandra O. Gollnick Original Article Open access 03 March 2018 Pages: 873 - 883
T-cell receptor-β V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patterns Blake M. CallahanJohn M. YavorskiGeorge Blanck Original Article 05 March 2018 Pages: 885 - 892
CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8+ T cells to Tc1 phenotype Bhushan DharmadhikariEmily NicklesHerbert Schwarz Original Article 05 March 2018 Pages: 893 - 905
Rational combinations of in vivo cancer antigen priming and adoptive T-cell therapy mobilize immune and clinical responses in terminal cancers Qing Zhao RuanJian Qian FuRun Sheng Ruan Original Article 06 March 2018 Pages: 907 - 915
Rituximab as a therapeutic option for patients with advanced melanoma Julia K. WinklerMatthias SchillerJessica C. Hassel Original Article 07 March 2018 Pages: 917 - 924
Enhanced expression of PD-1 and other activation markers by CD4+ T cells of young but not old patients with metastatic melanoma Rob R. H. van den BromKornelis S. M. van der GeestAnnemieke M. H. Boots Original Article Open access 15 March 2018 Pages: 925 - 933
The novel deubiquitinase inhibitor b-AP15 induces direct and NK cell-mediated antitumor effects in human mantle cell lymphoma Korbinian N. KroppStefanie MaurerDaniela Dörfel Original Article 19 March 2018 Pages: 935 - 947
Quantitative T-cell repertoire analysis of peripheral blood mononuclear cells from lung cancer patients following long-term cancer peptide vaccination Kazuyoshi TakedaKazutaka KitauraHiroyuki Suzuki Original Article 22 March 2018 Pages: 949 - 964
Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals Javier Arranz-NicolásJesús OgandoAntonia Ávila-Flores Original Article 23 March 2018 Pages: 965 - 980
Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies Florent PetitprezYann A. VanoWolf H. Fridman Focussed Research Review 07 September 2017 Pages: 981 - 988
T cell responses to tumor: how dominant assumptions on immune activity led to a neglect of pathological functions, and how evolutionary considerations can help identify testable hypotheses for improving immunotherapy Marinos Kallikourdis Focussed Research Review 15 January 2018 Pages: 989 - 998
Defective HLA class I antigen processing machinery in cancer Lei CaiTheodoros MichelakosSoldano Ferrone Focussed Research Review 27 February 2018 Pages: 999 - 1009
The non-small cell lung cancer immune landscape: emerging complexity, prognostic relevance and prospective significance in the context of immunotherapy Andrea AnichiniElena TassiRoberta Mortarini Focussed Research Review 07 March 2018 Pages: 1011 - 1022
Fourteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 13–15, 2016 Vincenzo RussoCarla ChiarucciMichele Maio Meeting Report 20 October 2017 Pages: 1023 - 1030